A risk assessment of disease progression after virus elimination with chronic hepatitis C
With reference to various clinical studies on interferon-α and pegylated interferon-α around the world, patients with chronic hepatitis C who receive antiviral therapy and achieve the elimination of hepatitis C virus may have significant relief or even reversion of liver fibrosis, as well as reducti...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2018-02-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8807 |